“The number of people with diabetes has nearly quadrupled since 1980 to 415 million adults today, and by 2040 is set to rise to 642 million, equating to roughly 10% of the global adult population aged between 20 and 79 years”
(International Diabetes Federation, 2015).
No country is safe from the challenge of diabetes which disables people during their working age, limiting earning potential, reducing the life expectancy and impoverishing families. In turn, this diminishes countries’ productivity and hinders economic growth. Providing diabetes care drains healthcare spending and can disrupt entire health systems. For this reason, control of diabetes is a priority for non-communicable diseases as part of the United Nation’s Sustainable Development Goal 3 – to ensure healthy lives and well-being for all.
The recent Diabetic Retinopathy Barometer Study investigated global, regional, and specific country issues surrounding diabetic eye disease. Collecting quantitative and qualitative data from more than 4000 adults with diabetes and 2000 health professionals across 41 countries, it aimed to provide an understanding of the local, regional and global challenges being faced by people with diabetes and their families, and by health providers and health systems.
Below, we excerpt some of the figures and quotes from the study’s report to highlight its key findings in three areas:
Understanding eye disease as a complication of diabetes
People with diabetes reported a lack of awareness and acceptance of eye complications, often whilst they were asymptomatic.
“I can’t see properly, everything looks blurry, my eyes seem burning. I didn’t know that eye diseases were linked with diabetes.” A person with diabetes, age 32, Bangladesh
“Yes, he told me frankly, that I should go and examine my eyes and meticulously follow up with the ophthalmologists. However, as I mentioned, I did not obey at the beginning. Sometimes, I would lie to him and say, “Yes, I did.” Only when I felt a problem I started following up meticulously.” A person with diabetes, age 60, Saudi Arabia
“We are trying to draw their attention to the need for periodic ophthalmologic examinations. But unfortunately, we do not succeed 100% every time. A lot of our patients do not understand why they should come, even if they do not have anything with their eyes. “Why should I come?” they ask us. “Nothing upsets me,” they say.” Ophthalmologist, Romania
People with diabetes and visual loss from diabetic retinopathy (DR) or diabetic macular oedema (DME) reported various impacts: loss of confidence, loss of activity and income, mental health concerns and dependency on others
• 79% said their vision impairment made everyday activities difficult, such as driving, working and cooking or cleaning their home, and in some cases
• 69% of those with DME experienced days of poor physical and mental health.
• 20% said their vision impairment made it difficult to manage their diabetes “Sometimes…I am in a hall for a social occasion, and I get very shy because I can not really recognise a relative or friend’s face.” A person with diabetes, age 60, Saudi Arabia.
“My son has been very helpful. He is the one that also helps me buy things. If I get really bad, he takes me to the doctor. Right now, he’s asking me a lot of details about my diabetes. I guess the person that he’s talking to is asking him all of those things.” A person with diabetes, age 50, Mexico
Difficulties in accessing and providing quality eye care
Cost, distance, waiting times, resources, training and whether a team approach was taken affected people with diabetes’ access to eye care
“What I really miss is the real link between the doctors. Everyone is just interested in his own topic, and that’s it. Yes, they warn about other issues, but maybe once and that’s it. They never follow up.” A Person with diabetes, age 56, Saudi Arabia.
“Patients … who need treatment require frequent clinic visits, but they are the working generation…, so they cannot take a day off for this. …they have difficulty in visiting the clinic. And say laser treatment or anti-VEGF treatment for diabetic macular oedema cost quite a lot, and that makes patients hesitate to have treatment, …not all cases, but some,… so that can be a barrier to the services.” Ophthalmologist, Japan.
“[Patients] wait an irrational amount of time. There are patients who cannot get an appointment until four, five, six months later or more, in order to be seen when their condition must be treated as soon as possible. I think this is the main obstacle patients’ face – there are too many patients, and they can’t all be seen in a timely manner.” Ophthalmologist, Mexico
Health system challenges
Diabetes creates multiple challenges for health systems to achieve good health outcomes. Additional resources, training, guidelines and increased funding are needed to treat increasing numbers of people with diabetes.
“Of the 20 ophthalmologists in Buenos Aires, there are only two places that can treat retinopathy.” Diabetes educator, Argentina.
“The equipment is expensive. This has always been a challenge. That has been one of the de-motivating issues. So [providers] know that if they train, some may not get the equipment.” Ophthalmologist, Uganda.
Strategic and specific investments
Strategic and specific investments are essential to ensure the necessary training for increased numbers of health care personnel and to develop cost-effective and timely interventions. The goal should be to build sustainable business models for improved outcomes for diabetic eye diseases, as well as implementing national eye health policies and legislation to address the barriers to access and care.
The economic burden of diabetic retinopathy affects individuals, families and societies. For example, someone who can no longer work because of visual impairment from diabetic retinopathy requires family support, national welfare or disability funds and this drains resources.
An initial investment in a screening and treatment programme will prevent
unnecessary health care dollars being spent further down the road on
complications, surgery and advanced treatment for DR. In addition, the years of work people with diabetes gain from improved eyesight will directly benefit the economy and benefit the health care system on the whole. Research demonstrates that diabetes is among the top ten causes of death globally and – with the other three major non-communicable diseases (NCDs) of cardiovascular disease, cancer and respiratory disease – accounts for over 80% of all premature NCD deaths.
Effective multi-sectoral, interdisciplinary and co-ordinated responses using national and international public policies and timely interventions within and beyond the health sector, must be applied to overcome this devastating burden.